Long-term Safety of Hepatic Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitors
- 14 August 2000
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 160 (15) , 2273-2280
- https://doi.org/10.1001/archinte.160.15.2273
Abstract
Review from JAMA Internal Medicine — Long-term Safety of Hepatic Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitors — The Role of Metabolism—Monograph for PhysiciansThis publication has 14 references indexed in Scilit:
- Drug Interactions Analysis and Management 2009Medicine & Science in Sports & Exercise, 2009
- Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-Analysis of Prospective StudiesSurvey of Anesthesiology, 1999
- The interaction of diltiazem with lovastatin and pravastatinPublished by Wiley ,1998
- Effect of itraconazole on the pharmacokinetics of atorvastatin*Clinical Pharmacology & Therapeutics, 1998
- Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole*Clinical Pharmacology & Therapeutics, 1998
- Potential Interaction between Warfarin and FluvastatinAnnals of Pharmacotherapy, 1996
- Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acidClinical Pharmacology & Therapeutics, 1996
- In vivo inhibition profile of cytochrome P450TB (CYP2C9) by (±)-fluvastatin*Clinical Pharmacology & Therapeutics, 1995
- Rhabdomyolysis from the Coadministration of Lovastatin and the Antifungal Agent ItraconazoleNew England Journal of Medicine, 1995
- The Medical Letter Handbook of Adverse Drug InteractionsCritical Care Medicine, 1986